Existing monoclonal antibody development technologies ... The Beacon ® system is currently able to screen mouse and human plasma cells. The screening of rabbit plasma cells is currently under ...

Human monoclonal antibodies are increasingly being used to prevent or treat infectious diseases. The list of key features needed to identify promising leads that can be developed as biological drugs ...

1 Step 4: Screening Researchers often screen hybridoma cells for the monoclonal antibody of interest using an enzyme-linked immunosorbent assay (ELISA). Indirect ELISAs identify antibodies with the ...

Cell lines commonly used for monoclonal antibody expression include Chinese hamster ovary (CHO) and human embryonic kidney 293 (HEK293) cells. But even if researchers have worked with these wild ...

Since monoclonal antibodies are highly specific for a single antigen, researchers wanted to leverage this ability to specifically target cancer cells. However, at the time, their pursuits to use these ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Our systems make the development of new biopharmaceuticals faster and more cost-effective, improve monoclonal antibody screening, cell line development, and overall research efficiency in a number ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

Monoclonal gammopathy of undetermined significance (MGUS ... Like multiple myeloma, MGUS starts in a type of white blood cell called plasma cells. These cells make m-protein. This abnormal protein can ...